RESUMEN
Equid herpesvirus 1 is one of the most common viral pathogens in the horse population and is associated with respiratory disease, abortion and still-birth, neonatal death and neurological disease. A single point mutation in the DNA polymerase gene (ORF30: A2254G, N752D) has been widely associated with neuropathogenicity of strains, although this association has not been exclusive. This study describes the fortuitous isolation of a strain carrying a new genotype C2254 (H752) from an outbreak in France that lasted several weeks in 2018 and involved 82 horses, two of which showed neurological signs of disease. The strain was characterised as UL clade 10 using the equid herpesvirus 1 (EHV-1) multi-locus sequence typing (MLST) classification but has not been identified or isolated since 2018. The retrospective screening of EHV-1 strains collected between 2016 and 2018 did not reveal the presence of the C2254 mutation. When cultured in vitro, the C2254 EHV-1 strain induced a typical EHV-1 syncytium and cytopathic effect but no significant difference was observed when compared with A2254 and G2254 EHV-1 strains. An experimental infection was carried out on four Welsh mountain ponies to confirm the infectious nature of the C2254 strain. A rapid onset of marked respiratory disease lasting at least 2 weeks, with significant virus shedding and cell-associated viraemia, was observed. Finally, an in vitro antiviral assay using impedance measurement and viral load quantification was performed with three antiviral molecules (ganciclovir (GCV), aciclovir (ACV) and aphidicolin (APD)) on the newly isolated C2254 strain and two other A/G2254 field strains. The three strains showed similar sensitivity to ganciclovir and aphidicolin but both C2254 and A2254 strains were more sensitive to aciclovir than the G2254 strain, based on viral load measurement.
Asunto(s)
ADN Polimerasa Dirigida por ADN/genética , Infecciones por Herpesviridae/veterinaria , Herpesvirus Équido 1/genética , Herpesvirus Équido 1/patogenicidad , Proteínas Virales/genética , Animales , Brotes de Enfermedades/veterinaria , Francia/epidemiología , Genotipo , Infecciones por Herpesviridae/virología , Herpesvirus Équido 1/enzimología , Enfermedades de los Caballos/epidemiología , Enfermedades de los Caballos/virología , Caballos/virología , Masculino , Mutación , Sistemas de Lectura Abierta , Estudios Retrospectivos , Carga ViralRESUMEN
The serine-threonine protein kinase encoded by US3 gene (pUS3) of alphaherpesviruses was shown to modulate actin reorganization, cell-to-cell spread, and virus egress in a number of virus species. However, the role of the US3 orthologues of equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) has not yet been studied. Here, we show that US3 is not essential for virus replication in vitro. However, growth rates and plaque diameters of a US3-deleted EHV-1 and a mutant in which the catalytic active site was destroyed were significantly reduced when compared with parental and revertant viruses or a virus in which EHV-1 US3 was replaced with the corresponding EHV-4 gene. The reduced plaque sizes were consistent with accumulation of primarily enveloped virions in the perinuclear space of the US3-negative EHV-1, a phenotype that was also rescued by the EHV-4 orthologue. Furthermore, actin stress fiber disassembly was significantly more pronounced in cells infected with parental EHV-1, revertant, or the recombinant EHV-1 expressing EHV-4 US3. Finally, we observed that deletion of US3 in EHV-1 did not affect the expression of adhesion molecules on the surface of infected cells.
Asunto(s)
Actinas/metabolismo , Herpesvirus Équido 1/enzimología , Herpesvirus Équido 1/fisiología , Interacciones Huésped-Patógeno , Proteínas Serina-Treonina Quinasas/metabolismo , Liberación del Virus , Línea Celular , Técnicas de Inactivación de Genes , Herpesvirus Équido 1/crecimiento & desarrollo , Humanos , Proteínas Serina-Treonina Quinasas/genética , Ensayo de Placa Viral , Proteínas Virales/genética , Proteínas Virales/metabolismoRESUMEN
A single nucleotide polymorphism in the equine herpesvirus 1 (EHV-1) DNA polymerase gene (ORF30 A(2254) to G) has been associated with clinical signs of equine herpes myeloencephalopathy (EHM). The purpose of our study was to determine the odds ratio for this genetic marker and EHM using a panel of field isolates from North America collected over the past twenty-three years. EHV-1 isolates cultured at the Cornell University Animal Health Diagnostic Laboratory from 1984 to 2007 were retrieved along with their clinical histories. DNA was extracted from these EHV-1 cultures and allelic discrimination was performed using real-time PCR. The results were confirmed by sequencing of the target region in ORF30. PCR and sequencing were in 100% agreement and showed that 19 out of the 176 isolates had the ORF30 G(2254) allele (11%), of which 16 were EHM cases and 3 respiratory or abortion cases. The odds of having neurologic disease with the ORF30 G(2254) genotype were computed as 162 times greater than those with the opposite allele ORF30 A(2254) (95% confidence interval: 35-742). Despite this strong statistical significance, 24% (5/21) of horses with neurologic disease in our study population harbored the "non-neurologic" form of the allele (ORF30 A(2254)), suggesting that other factors may also contribute to the onset of EHM.
Asunto(s)
ADN Polimerasa Dirigida por ADN/genética , Infecciones por Herpesviridae/veterinaria , Herpesvirus Équido 1/genética , Enfermedades de los Caballos/virología , Polimorfismo de Nucleótido Simple , Aborto Veterinario/epidemiología , Aborto Veterinario/virología , Animales , Femenino , Infecciones por Herpesviridae/epidemiología , Infecciones por Herpesviridae/genética , Infecciones por Herpesviridae/virología , Herpesvirus Équido 1/enzimología , Herpesvirus Équido 1/aislamiento & purificación , Enfermedades de los Caballos/epidemiología , Caballos , Humanos , Enfermedades Neurodegenerativas/epidemiología , Enfermedades Neurodegenerativas/veterinaria , Enfermedades Neurodegenerativas/virología , América del Norte/epidemiología , Embarazo , Estudios RetrospectivosRESUMEN
Infection with equid herpesvirus type 1 (EHV-1) leads to respiratory disease, abortion, and neurologic disorders in horses. Molecular epidemiology studies have demonstrated that a single nucleotide polymorphism resulting in an amino acid variation of the EHV-1 DNA polymerase (N752/D752) is significantly associated with the neuropathogenic potential of naturally occurring strains. To test the hypothesis that this single amino acid exchange by itself influences neuropathogenicity, we generated recombinant viruses with differing polymerase sequences. Here we show that the N752 mutant virus caused no neurologic signs in the natural host, while the D752 virus was able to cause inflammation of the central nervous system and ataxia. Neurologic disease induced by the D752 virus was concomitant with significantly increased levels of viremia (p = 0.01), but the magnitude of virus shedding from the nasal mucosa was similar between the N752 and D752 viruses. Both viruses replicated with similar kinetics in fibroblasts and epithelial cells, but exhibited differences in leukocyte tropism. Last, we observed a significant increase (p < 0.001) in sensitivity of the N752 mutant to aphidicolin, a drug targeting the viral polymerase. Our results demonstrate that a single amino acid variation in a herpesvirus enzyme can influence neuropathogenic potential without having a major effect on virus shedding from infected animals, which is important for horizontal spread in a population. This observation is very interesting from an evolutionary standpoint and is consistent with data indicating that the N752 DNA pol genotype is predominant in the EHV-1 population, suggesting that decreased viral pathogenicity in the natural host might not be at the expense of less efficient inter-individual transmission.
Asunto(s)
ADN Polimerasa Dirigida por ADN/genética , Infecciones por Herpesviridae/veterinaria , Herpesvirus Équido 1/enzimología , Herpesvirus Équido 1/genética , Herpesvirus Équido 1/patogenicidad , Enfermedades de los Caballos/genética , Secuencia de Aminoácidos , Animales , Antivirales/farmacología , Afidicolina/farmacología , Western Blotting , Linfocitos T CD4-Positivos/virología , Cromosomas Artificiales Bacterianos , ADN Polimerasa Dirigida por ADN/química , ADN Polimerasa Dirigida por ADN/efectos de los fármacos , Femenino , Genotipo , Infecciones por Herpesviridae/patología , Enfermedades de los Caballos/enzimología , Caballos , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Mutación Puntual , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Relación Estructura-ActividadRESUMEN
We report the expression and characterization of the putative catalytic subunit (pORF30) and accessory protein (pORF18) of equine herpesvirus 1 DNA polymerase, which are encoded by open reading frames 30 and 18 and are homologous to herpes simplex virus type 1 UL30 and UL42, respectively. In vitro transcription-translation of open reading frames 30 and 18 generated proteins of 136 and 45 kDa, respectively. In vitro-expressed pORF30 possessed basal DNA polymerase activity that was stimulated by pORF18, as measured by DNA polymerase assays in vitro. Purified baculovirus-expressed pORF30 exhibited DNA polymerase activity similar to that of the in vitro-expressed protein, and baculovirus-expressed pORF18 could stimulate both nucleotide incorporation and long-chain DNA synthesis by pORF30 in a dose- and time-dependent manner. The salt optima for activity of both pORF30 and the holoenzyme were substantially different from those for other herpesvirus DNA polymerases. As demonstrated by yeast two-hybrid assays, pORF30 and pORF18 could physically interact, most likely with a 1:1 stoichiometry. Finally, by mutational analysis of the 1,220-residue pORF30, we demonstrated that the extreme C terminus of pORF30 is important for physical and functional interaction with the accessory protein, as reported for UL30 and other herpesvirus DNA polymerases. In addition, a C-proximal region of pORF30, corresponding to residues 1114 to 1172, is involved in binding to, and stimulation by, pORF18. Taken together, the results indicate that pORF30 and pORF18 are the equine herpesvirus 1 counterparts of herpes simplex virus type 1 UL30 and UL42 and share many, but not all, of their characteristics.
Asunto(s)
ADN Polimerasa Dirigida por ADN/genética , Herpesvirus Équido 1/genética , Sistemas de Lectura Abierta/genética , Proteínas Virales/genética , Sustitución de Aminoácidos , Baculoviridae , Dominio Catalítico/genética , Sistema Libre de Células , Clonación Molecular , ADN Viral/biosíntesis , ADN Viral/química , ADN Polimerasa Dirigida por ADN/química , Exodesoxirribonucleasas/genética , Expresión Génica , Herpesvirus Équido 1/enzimología , Holoenzimas/química , Holoenzimas/genética , Unión Proteica/genética , Estructura Terciaria de Proteína/genética , Homología de Secuencia de Aminoácido , Técnicas del Sistema de Dos Híbridos , Proteínas Virales/químicaRESUMEN
The herpes simplex virus type 1 DNA polymerase consists of a catalytic subunit (POL or UL30) and a processivity factor (UL42). The POL/UL42 interaction, which occurs through the extreme C-terminus of POL, is essential for HSV-1 replication and thus represents a valid target for drug inhibition. We recently showed (A. Loregian et al. (1999) Proc. Natl. Acad. Sci. USA 96, 5221-5226) that an oligopeptide corresponding to the 27 C-terminal amino acids of POL, when delivered into herpes simplex virus type 1-infected cells by a protein carrier, was able to localize into the nucleus and to inhibit viral replication by disruption of the POL/UL42 interaction. In this report, to further characterize the 27 mer (Pol peptide), we investigated whether its nuclear localization was due to the presence of a nuclear localization signal. By testing the ability of the Pol peptide to localize the beta-galactosidase, a normally cytoplasmic protein, to the nucleus, we confirmed that the Pol peptide contained a functional nuclear localization signal, corresponding to the RRMLHR motif. This sequence proved not only necessary but also sufficient for nuclear localization, because its substitution with a six-alanine stretch prevented nuclear translocation of the beta-galactosidase-Pol peptide fusion. Site-directed mutagenesis experiments on this revealed that both the three basic arginines and the two hydrophobic residues Met and Leu were crucial for nuclear targeting. Finally, functionally equivalent sequences were also found in the C-terminus of the catalytic subunits of human cytomegalovirus (RRLHL) and of equine herpesvirus-1 DNA polymerase (RRILH).
Asunto(s)
Dominio Catalítico , ADN Polimerasa Dirigida por ADN/química , ADN Polimerasa Dirigida por ADN/metabolismo , Exodesoxirribonucleasas/química , Exodesoxirribonucleasas/metabolismo , Herpesvirus Humano 1/enzimología , Señales de Localización Nuclear , Proteínas Virales/metabolismo , Secuencia de Aminoácidos , Animales , Sitios de Unión , Transporte Biológico , Núcleo Celular/metabolismo , Chlorocebus aethiops , Citomegalovirus/enzimología , Citoplasma/metabolismo , ADN Polimerasa Dirigida por ADN/genética , Exodesoxirribonucleasas/genética , Técnica del Anticuerpo Fluorescente Indirecta , Herpesvirus Équido 1/enzimología , Datos de Secuencia Molecular , Mutación/genética , Señales de Localización Nuclear/genética , Señales de Localización Nuclear/fisiología , Unión Proteica , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Transfección , Células Vero , beta-Galactosidasa/genética , beta-Galactosidasa/metabolismoRESUMEN
Previous work revealed that the Us (unique short) segment of equine herpesvirus type-1 (EHV-1), like that of other alphaherpesviruses, encodes a serine/threonine protein kinase (PK). Experiments were carried out to identify the PK encoded by the EHV-1 EUS2 gene (ORF 69) and to ascertain its time course of synthesis and cellular localization. Western blot and immunoprecipitation analyses of EHV-1-infected cell extracts using a PK-specific polyclonal antibody generated against a bacterially expressed TrpE/PK fusion protein identified the Us PK as a 42- to 45-kDa phosphoprotein. The PK protein is first synthesized at 3 hr postinfection, is produced throughout the infection cycle, and is incorporated into EHV-1 virions. Interestingly, immunoprecipitation analyses revealed that the PK protein within the cytoplasm is associated with the 33-kDa IR6 novel protein of EHV-1, is expressed abundantly as an early protein, and is present in the large rod-like structures formed by the IR6 protein (ORF67 protein) within the cytoplasm of infected cells. Confocal microscopic examination of cells stained with fluorescein-labeled antibody clearly showed that the PK protein colocalized with the cytoplasmic IR6 rod-like structures and remained associated with these unique structures during infection. In contrast, in cells infected with the EHV-1 RacM strain in which the IR6 protein harbors four amino acid substitutions that prevent formation of the rod-like structures (Osterrieder et al., 1996, Virology 217, 442-451), the PK protein localized predominantly to the nucleus. The possible significance of the association of the IR6 and PK proteins in EHV-1 replication is discussed.
Asunto(s)
Herpesvirus Équido 1/enzimología , Fosfoproteínas/metabolismo , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Virales/metabolismo , Animales , Anticuerpos Antivirales/inmunología , Línea Celular , Núcleo Celular/virología , Citoplasma/metabolismo , Microscopía Confocal , Microscopía Inmunoelectrónica , Fosfoproteínas/ultraestructura , Proteínas Serina-Treonina Quinasas/ultraestructura , Conejos , Proteínas Virales/ultraestructuraRESUMEN
Both intranasal (i.n.) and intracerebral (i.c.) inoculation of mice with wild-type equine herpesvirus type 1 (wt EHV-1) caused clinical signs and mortality. Virus could be recovered from target organs (turbinates, lungs and blood) for several days. By contrast, the thymidine kinase (TK)-deficient deletion mutant PR1 produced markedly less clinical disease following both i.n. and i.c. inoculation, and, in particular, no mortality occurred. PR1 did, however, establish productive infections following either route of inoculation. High titres of virus were recovered from target organs although virus did not persist for as long as wt EHV-1 and no viraemia was detected. Primary i.n. infection of mice with either wt EHV-1 or PR1 protected against subsequent challenge with wt EHV-1 5 weeks later. I.n. inoculation of specific pathogen-free (EHV-free) foals with PR1 produced results similar to those observed after infection of mice. Clinical signs were milder than for wt EHV-1 and pyrexia was short-lived or absent. PR1 could be recovered from nasal mucus at high titres but it persisted for only 5 days post-infection compared to 11 days in the case of wt EHV-1. No viraemia was detected in foals infected with PR1. On challenge with wt EHV-1, foals given a primary infection with the mutant were partially protected; but a viraemia with a TK+ EHV-1 was observed. These results demonstrate that our TK- mutant PR1 is markedly less pathogenic than wt EHV-1, despite being able to replicate in the host. The use of TK-deficient mutants of EHV-1 as potential vaccines in the horse is discussed.
Asunto(s)
Infecciones por Herpesviridae/microbiología , Herpesvirus Équido 1/patogenicidad , Timidina Quinasa/metabolismo , Animales , Animales Recién Nacidos , Línea Celular , Corteza Cerebral/microbiología , Femenino , Herpesvirus Équido 1/enzimología , Herpesvirus Équido 1/genética , Caballos , Ratones , Ratones Endogámicos BALB C , Mutación , Mucosa Nasal/microbiología , Conejos , Organismos Libres de Patógenos Específicos , Timidina Quinasa/genéticaRESUMEN
We have amplified, cloned and sequenced the gene encoding the thymidine kinase (TK) of a wild-type strain (Ab4) of equine herpesvirus-1 (EHV-1) and two mutants with defective TK activity isolated for resistance to penciclovir (PCV). One of the mutants, PR1, has suffered a 879-bp deletion which reduces the size of TK to 180 bp. The other mutant, PR3, has an adenine to cytosine mutation resulting in a Lys38-->Thr change. This mutation modifies the amino acid sequence of a domain involved in binding ATP, leading to non-detectable enzymatic activity. Lys38 thus appears to be essential for the activity of the TK of EHV-1.
Asunto(s)
Herpesvirus Équido 1/genética , Mutación , Timidina Quinasa/genética , Secuencia de Aminoácidos , Secuencia de Bases , ADN Viral , Virus Defectuosos , Herpesvirus Équido 1/enzimología , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Eliminación de Secuencia , Timidina Quinasa/metabolismo , Vacunas Virales/genéticaRESUMEN
EHV-1 was inoculated into specific pathogen-free (SPF) foals in order to study uncomplicated primary responses. Infection resulted in a strong serological response recognizing EHV-1-specific antigens; this contrasts with a previous publication where a weak response was recorded in SPF animals. Antibodies to EHV-1 were readily detected by four techniques (virus neutralization, complement fixation, Western blots and immune precipitation), yet there was comparatively little cross-reaction to EHV-4 target antigen. Re-inoculation with the same virus strain stimulated antibodies to EHV-1 but no additional antigens were recognized and antibodies cross-reacting with EHV-4 antigens were not enhanced. Having characterized the uncomplicated primary response to EHV-1 in SPF foals, further animals were exposed to either EHV-4 or a thymidine kinase-deficient mutant of EHV-1 prior to challenge with w/t EHV-1 to investigate how these infections might modulate the immune responses to EHV-1 or 4. Primary inoculation with EHV-4 or with a thymidine kinase-deficient mutant of EHV-1 produced productive infections as evidenced by virus shedding and pyrexia. In both these cases, however, in contrast to that with w/t EHV-1, the serological response was very weak. Re-infection of foals primed with either EHV-4 or TK-deficient EHV-1 with w/t EHV-1 resulted in a strong response to EHV-1 antigens detected by all four methods. In addition, in the foals given a primary inoculation with EHV-4, superinfection with EHV-1 resulted in a strong cross-reactive response to EHV-4 target antigens. The relevance of these observations to the interpretation of previously reported serological responses to EHVs in SPF and naturally reared animals is discussed.
Asunto(s)
Infecciones por Herpesviridae/veterinaria , Herpesvirus Équido 1/inmunología , Enfermedades de los Caballos/inmunología , Animales , Anticuerpos Antivirales/biosíntesis , Anticuerpos Antivirales/inmunología , Antígenos Virales/inmunología , Western Blotting , Línea Celular , Reacciones Cruzadas , Glicoproteínas/inmunología , Herpesviridae/inmunología , Infecciones por Herpesviridae/inmunología , Infecciones por Herpesviridae/microbiología , Herpesvirus Équido 1/enzimología , Herpesvirus Équido 1/aislamiento & purificación , Enfermedades de los Caballos/microbiología , Caballos , Conejos , Organismos Libres de Patógenos Específicos , Timidina Quinasa/metabolismoRESUMEN
The synthetic nonapeptide YAGAVVNDL [identical to the nine carboxy-terminal amino acids of the small subunit of herpes simplex virus (HSV)-encoded ribonucleotide reductase (RR)] was found to inhibit the RR activity induced by equine herpesvirus type 1 subtype 1 (EHV-1). Parallel experiments with HSV type 1 (HSV-1)-encoded RR established that the concentration of peptide required to inhibit 50% of the RR activity was 28 microM for both enzymes. The optimum pH for the EHV-1 enzyme was found to be between 8.0 and 8.1 which is the same as that of HSV-1 RR. By use of antisera made against peptides corresponding to different regions of the large subunit (RR1) of the HSV-1 enzyme and monoclonal antibodies directed against HSV-1 RR1 we have obtained evidence which suggests that the EHV-1 large subunit has an Mr of approximately 90,000 and lacks the N-terminal domain which is so far unique to HSV.
Asunto(s)
Herpesviridae/enzimología , Herpesvirus Équido 1/enzimología , Oligopéptidos/farmacología , Ribonucleótido Reductasas/antagonistas & inhibidores , Secuencia de Aminoácidos , Anticuerpos Monoclonales/inmunología , Concentración de Iones de Hidrógeno , Datos de Secuencia Molecular , Peso Molecular , Ribonucleótido Reductasas/inmunología , Simplexvirus/enzimologíaRESUMEN
A drug induced equine herpesvirus-1 (EHV-1) mutant lacking thymidine kinase inducing activity was developed and evaluated as a vaccine. The safety and effectiveness of the vaccine to protect against experimentally induced EHV-1 respiratory disease were evaluated in weanling horses free of EHV-1 neutralizing antibody. The vaccine was safe when administered either intramuscularly or intravenously, and EHV-1 was not shed intranasally during the 12 days following administration. Intranasal challenge with virulent EHV-1 was used to evaluate vaccine efficacy. Following challenge, there was a significantly (p less than 0.05) greater increase in peak body temperatures and duration of nasal virus shedding in the nonvaccinates, and a significant (p less than 0.05) increase in serum neutralizing antibody titers in the vaccinates.
Asunto(s)
Infecciones por Herpesviridae/veterinaria , Herpesviridae/inmunología , Herpesvirus Équido 1/inmunología , Enfermedades de los Caballos/prevención & control , Timidina Quinasa/biosíntesis , Vacunas Virales , Animales , Anticuerpos Antivirales/biosíntesis , Temperatura Corporal , ADN Viral/análisis , Electroforesis en Gel de Agar , Inducción Enzimática , Infecciones por Herpesviridae/prevención & control , Herpesvirus Équido 1/enzimología , Herpesvirus Équido 1/genética , Caballos , Recuento de Leucocitos/veterinaria , Mutación , Neutrófilos , Mapeo Restrictivo , Timidina Quinasa/genética , Vacunación/veterinaria , Vacunas Virales/inmunologíaRESUMEN
We have identified the equine herpesvirus 1 (EHV-1) thymidine kinase gene (TK) by DNA-mediated transformation and by DNA sequencing. Alignment of the amino acid sequence of the EHV-1 TK with the TKs from 3 other herpesviruses revealed regions of homology, some of which correspond to the previously identified substrate binding sites, while others have as yet, no assigned function. In particular, the strict conservation of an aspartate within the proposed nucleoside binding site suggests a role in ATP binding for this residue. Comparison of 5 herpes TKs with the thymidylate kinase of yeast revealed significant similarity which was strongest in those regions important to catalytic activity of the herpes TKs, and, therefore we propose that the herpes TK may be derived from a cellular thymidylate kinase. The implications for the evolution of enzyme activities within a pathway of nucleotide metabolism are discussed.
Asunto(s)
Secuencia de Bases , Herpesviridae/enzimología , Herpesvirus Équido 1/enzimología , Nucleósido-Fosfato Quinasa/genética , Fosfotransferasas/genética , Homología de Secuencia de Ácido Nucleico , Timidina Quinasa/genética , Secuencia de Aminoácidos , Animales , Línea Celular Transformada , Genes , Herpesvirus Équido 1/genética , Ratones , Datos de Secuencia Molecular , Saccharomyces cerevisiae/enzimología , Timidina Quinasa/aislamiento & purificaciónRESUMEN
Thymidine kinase (TK) enzymes encoded by herpes simplex viruses types 1 and 2 (HSV-1, HSV-2), and equine herpesvirus type 1 (EHV-1) catalyze the phosphorylation of thymidine (dThd) and (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU). The replication of HSV-1 is sensitive to BVDU, but the replication of HSV-2 and EHV-1 is not. To investigate the differential sensitivity of the viruses to halogenated vinyldeoxyuridine drugs, the phosphorylation of 125I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU) was studied. Cytosol enzymes from cells infected by HSV-2 and EHV-1 phosphorylated [125I]IVDU to the monophosphate, IVDUMP, but did not convert IVDUMP to higher di- plus triphosphates (IVDUDP plus IVDUTP) forms. In contrast, enzymes from HSV-1-infected cells converted [125I]IVDU to radioactive IVDUMP and IVDUDP plus IVDUTP. Experiments with mixtures of EHV-1- and HSV-1-induced enzymes showed that the EHV-1 enzyme did not inhibit formation of the IVDUDP plus IVDUTP by the HSV-1 enzyme. With [125I]IVDU as substrate, the Km values for the EHV-1 and HSV-1 TKs were 1.82 and 0.34 microM, respectively, and the Ki (dThd) value for the EHV-1 TK was 0.35 microM. In vivo experiments showed that HSV-1-infected cells converted IVDU to the mono- and the di- plus triphosphate forms. In contrast, EHV-1-infected cells converted IVDU to the monophosphate to a lesser extent than did HSV-1-infected cells, and did not produce the di- plus triphosphates. Thus, inefficient phosphorylation of the monophosphates probably contributes to the insensitivity of EHV-1 replication to IVDU, as it does to the insensitivity of HSV-2 replication to this drug.
Asunto(s)
Antivirales/metabolismo , Herpesviridae/enzimología , Herpesvirus Équido 1/enzimología , Idoxuridina/análogos & derivados , Simplexvirus/enzimología , Timidina Quinasa/metabolismo , Animales , Línea Celular , Citosol/enzimología , Idoxuridina/metabolismo , Cinética , Fosforilación , Células VeroRESUMEN
Replication of equine herpesvirus type 1 (EHV-1) was sensitive to 9-(1,3-dihydroxy-2-propoxymethyl)guanine(DHPG) but relatively resistant to E-5-(2-bromovinyl)-2'-deoxyuridine (BVDU). Likewise, plaque formation by EHV-1 was inhibited by DHPG, but not by BVDU. Plaque formation by a thymidine kinase-negative (tk-) mutant of EHV-1 was not inhibited by DHPG. In order to investigate biochemical mechanisms determining the differential sensitivity of EHV-1 to these drugs, the EHV-1-encoded thymidine kinase enzyme activity (TK)1 was partially purified from EHV-1-infected cells and analyzed. The EHV-1-induced enzyme utilized both ATP and CTP as phosphate donors and differed in relative electrophoretic mobility from the TKs of mock-infected and HSV-1-infected cells. Phosphorylation of 3H-dThd by the EHV-1 TK was inhibited by AraT, IdUrd, BVDU, and DHPG. The EHV-1 TK phosphorylated 125I-dCyd and 3H-ACV. The results indicate that EHV-1 encodes a pyrimidine deoxyribonucleoside kinase with broad nucleoside substrate specificity. These observations suggest that the failure of BVDU to inhibit EHV-1 replication is not attributable to an inability of the EHV-1 TK to phosphorylate BVDU, but may result from the incapacity of the viral TK to convert BVDU monophosphate to the triphosphate or from lack of inhibitory effect of BVDU triphosphate on viral DNA polymerase reactions.
Asunto(s)
Aciclovir/metabolismo , Desoxicitidina/metabolismo , Herpesviridae/enzimología , Herpesvirus Équido 1/enzimología , Fosfotransferasas (Aceptor de Grupo Alcohol) , Fosfotransferasas/metabolismo , Timidina Quinasa/metabolismo , Aciclovir/análogos & derivados , Aciclovir/farmacología , Adenosina Trifosfato/metabolismo , Animales , Bromodesoxiuridina/análogos & derivados , Bromodesoxiuridina/metabolismo , Bromodesoxiuridina/farmacología , Línea Celular , Células Cultivadas , Citidina Trifosfato/metabolismo , Efecto Citopatogénico Viral/efectos de los fármacos , Ganciclovir , Herpesvirus Équido 1/genética , Herpesvirus Équido 1/fisiología , Mutación , Fosforilación , Especificidad por Sustrato , Replicación Viral/efectos de los fármacosAsunto(s)
Herpesviridae/enzimología , Herpesvirus Équido 1/enzimología , Timidina Quinasa/metabolismo , Línea Celular , Cromatografía de Afinidad , Nucleótidos de Desoxicitosina/farmacología , Inducción Enzimática , Peso Molecular , Especificidad por Sustrato , Timidina Quinasa/biosíntesis , Timidina Quinasa/aislamiento & purificación , Nucleótidos de Timina/farmacologíaRESUMEN
DNA extracted from purified virions of equine herpesvirus type 1 (EHV-1) was examined for its transfectivity and transforming ability. The infectivity of the herpesvirus DNA was demonstrated by addition of calcium phosphate-DNA coprecipitates to monolayers of permissive horse cells, with resultant plaque formation. The efficiency of transfection (50 to 100 plaque-forming units/microgram of DNA) was reduced by treatment of the viral DNA with deoxyribonuclease or sonication but not with Pronase or antivirus neutralizing serum. When nonpermissive mouse 3T3 Cells lacking the enzyme thymidine kinase (TK-) were transfected with intact EHV-1 DNA, clones of cells transformed to the TK+ phenotype were isolated in selective HAT medium (hypoxanthine, aminopterin, thymidine), which prevents growth of the TK- parental phenotype. The efficiency of transformation ranged from one to five transformants per microgram of EHV-1 DNA. The TK activity of the biochemically transformed cells was characterized by biochemical, electrophoretic, and immunological techniques. By these criteria, the TK activity was identical to the EHV-1 TK and different from the host wild-type enzyme. In contrast to the parental TK+ 3T3 cells, the EHV-1-transformed TK+ cells were unable to grow in the presence of arabinosylthymine, a drug selectively phosphorylated by herpesvirus TKs. These results indicate that stable transfer of EHV-1 genes into nonpermissive cells can be achieved with purified viral DNA.
Asunto(s)
Transformación Celular Viral , ADN Viral/genética , Herpesviridae/genética , Herpesvirus Équido 1/genética , Transfección , Arabinonucleósidos/farmacología , División Celular/efectos de los fármacos , Línea Celular , Herpesvirus Équido 1/enzimología , Timidina/análogos & derivados , Timidina/farmacología , Timidina Quinasa/metabolismoAsunto(s)
Arabinonucleósidos/farmacología , Infecciones por Herpesviridae/tratamiento farmacológico , Animales , Arabinonucleósidos/metabolismo , Transformación Celular Neoplásica , Células Cultivadas , Cricetinae , Infecciones por Herpesviridae/metabolismo , Herpesvirus Équido 1/enzimología , Mesocricetus , Timidina Quinasa/metabolismoRESUMEN
A method for the purification of enveloped infectious equine herpesvirus type 1 (EHV-1) is presented. Virus from cell culture fluids harvested at 48 h post infection was concentrated by sedimentation and partially purified by differential precipitation with ammonium sulphate. The final steps of purification consisted of two cycles of flotation of virus in pre-formed CsCl density gradients. Yields of infectious virus were about 30% (18 to 44%) of that present in starting material. As judged by electron microscopy, mixed radioisotope labelling, and absence of phosphohydrolase, virus preparations possessed a high degree of purity. Sedimentation of EHV-1 into CsCl density gradients resulted in low recovery of infectious virus. Flotation of virus in CsCl gradients, however, was not deleterious to infectivity of viral preparations.